3 Promising TSX Penny Stocks With Market Caps Over CA$8M
The Canadian TSX index has seen an uptick since Inauguration Day, buoyed by a solid economic backdrop and positive earnings growth despite uncertainties surrounding new U.S. tariff policies. Penny stocks, often overlooked yet ripe with potential, refer to smaller or newer companies that can offer growth opportunities at lower price points. This article explores three promising TSX penny stocks that combine robust balance sheets with the potential for significant returns.
Name
Share Price
Market Cap
Financial Health Rating
Silvercorp Metals (TSX:SVM)
CA$4.29
CA$965.98M
★★★★★★
Mandalay Resources (TSX:MND)
CA$4.33
CA$432.92M
★★★★★★
Pulse Seismic (TSX:PSD)
CA$2.42
CA$124.04M
★★★★★★
Foraco International (TSX:FAR)
CA$2.26
CA$231.32M
★★★★★☆
Findev (TSXV:FDI)
CA$0.495
CA$13.75M
★★★★★★
PetroTal (TSX:TAL)
CA$0.68
CA$632.62M
★★★★★★
NamSys (TSXV:CTZ)
CA$1.00
CA$26.86M
★★★★★★
East West Petroleum (TSXV:EW)
CA$0.04
CA$4.07M
★★★★★★
Hemisphere Energy (TSXV:HME)
CA$1.83
CA$179.61M
★★★★★☆
DIRTT Environmental Solutions (TSX:DRT)
CA$1.16
CA$228.22M
★★★★☆☆
Click here to see the full list of 935 stocks from our TSX Penny Stocks screener.
Let's explore several standout options from the results in the screener.
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: Quipt Home Medical Corp., operating through its subsidiaries, provides durable and home medical equipment and supplies in the United States, with a market cap of CA$185.29 million.
Operations: Quipt Home Medical generates revenue of $245.92 million from providing durable and home medical equipment and supplies in the United States.
Market Cap: CA$185.29M
Quipt Home Medical, with a market cap of CA$185.29 million, operates in the U.S., generating US$245.92 million in revenue but remains unprofitable. Despite this, it has managed to reduce its debt-to-equity ratio significantly over five years and maintains a strong cash runway for over three years due to positive free cash flow growth. The company trades at a substantial discount compared to its estimated fair value and peers within the industry. Recent earnings show increased revenue but also higher net losses year-over-year, while management anticipates a return to historical organic growth rates in 2025.
Dive into the specifics of Quipt Home Medical here with our thorough balance sheet health report.
Learn about Quipt Home Medical's future growth trajectory here.
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: CopAur Minerals Inc. focuses on the acquisition, exploration, and development of mineral properties in Canada with a market cap of CA$8.36 million.
Operations: CopAur Minerals Inc. does not report any revenue segments as it is primarily engaged in the acquisition, exploration, and development of mineral properties in Canada.
Market Cap: CA$8.36M
CopAur Minerals, with a market cap of CA$8.36 million, is pre-revenue and primarily focused on mineral exploration in Canada. The company recently closed a private placement, raising CA$1.48 million to bolster its cash runway. Despite an experienced management team and satisfactory debt levels, CopAur faces financial challenges with short-term liabilities exceeding assets and ongoing net losses, including a CAD 2.15 million loss for the first quarter ending September 2024. Auditor concerns about the company's ability to continue as a going concern highlight the risks associated with this investment in penny stocks within the volatile mining sector.
Jump into the full analysis health report here for a deeper understanding of CopAur Minerals.
Gain insights into CopAur Minerals' historical outcomes by reviewing our past performance report.
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Morien Resources Corp. is a mining development company focused on acquiring mineral interests and projects in Canada, with a market cap of CA$12.82 million.
Operations: The company's revenue of CA$0.11 million is derived from the identification, purchase, exploration, and development of mineral properties.
Market Cap: CA$12.82M
Morien Resources Corp., with a market cap of CA$12.82 million, operates as a pre-revenue mining development company in Canada. Despite being debt-free and having sufficient cash runway for over two years, the company remains unprofitable with increasing losses over the past five years at 47.4% annually. Recent earnings results revealed a net loss of CA$0.15125 million for Q3 2024, highlighting ongoing financial challenges despite stable short-term asset coverage exceeding liabilities. The experienced board and management team provide some stability, but the lack of meaningful revenue underscores the inherent risks associated with investing in this penny stock within the mining sector.
Click here to discover the nuances of Morien Resources with our detailed analytical financial health report.
Assess Morien Resources' previous results with our detailed historical performance reports.
Investigate our full lineup of 935 TSX Penny Stocks right here.
Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive.
Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors.
Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
Jump on the AI train with fast growing tech companies forging a new era of innovation.
Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include TSX:QIPT TSXV:CPAU and TSXV:MOX.
Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@simplywallst.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
17 minutes ago
- Yahoo
MediPharm Announces Complete Dismissal of Dissident Court Proceeding Related to Annual and Special Meeting
TORONTO, June 11, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ('MediPharm' or the 'Company'), a pharmaceutical company specialized in precision-based cannabinoids, today announced that the Superior Court of Justice – Ontario (Commercial List) (the 'Court') has fully dismissed the application (CV-25-00743454-00CL) (the 'Application') issued by Apollo Technology Capital Corporation ('Apollo') and Nobul Technologies Inc. (together with Apollo, the 'Applicants') against the Company on May 16, 2025 (the 'Notice'). The Applicants sought an order from the Court, amongst other things, appointing a third-party independent chair to preside over the Annual and Special Meeting of Shareholders of the Company (the 'Meeting') on June 16, 2025. The Applicants argued that MediPharm has a 'design or plan to invalidate proxies' and that the Company had acted improperly warranting the appointment of a third-party independent chair. The Court dismissed the Application in full. In doing so, the Court found that a third-party independent chair was not required in the circumstances as there was no evidence or indication that MediPharm's proposed meeting chair will act unfairly at the Meeting. Regarding the conduct of Apollo's principal, Mr. Regan McGee, the Court found: 'The evidence shows that Mr. McGee has threatened to release a draft press release which, among other things, compared Mr. Pidduck to known serial killers. Press Releases have also been issued by Mr. McGee or the Applicants which accuse MediPharm and the Board of securities fraud, breach of fiduciary duty and running a corrupt election process to entrench themselves. Mr. McGee has threatened to sue the Board by way of a derivative action for breach of fiduciary duty and associated damages because of the rejection of the $3.4 million offer and has commenced a lawsuit against MediPharm, two of its senior officers and directors, as well as the Company's external litigation firm (Tyr LLP) and counsel (James Bunting) which claimed $50 million in damages. Mr. McGee, repeated the allegations set out in the lawsuit in the Dissident Circular and then abandoned and withdrew the claim against Tyr LLP and Mr. Bunting, and agreed to terms of settlement that included a declaration by Mr. McGee that Tyr LLP and Mr. Bunting are not in a conflict of interest in acting for MediPharm, that they had not misused confidential information, that Mr. McGee would not disparage Mr. Bunting or Tyr LLP and provided a full release to Tyr LLP and Mr. Bunting.' The Company remains committed to a fair shareholder meeting process, in compliance with its constating documents and all applicable laws. We encourage shareholders to please vote using ONLY the GREEN proxy or GREEN voting instruction card and to support each of the director nominees recommended by MediPharm's Board of Directors (the 'Board') and the other matters being considered at the Meeting. To ensure your proxy is counted at the Meeting, please submit it well in advance of the June 13 proxy cut-off. Vote for the Highly Qualified MediPharm Nominees MediPharm urges shareholders to vote only using the GREEN proxy or GREEN voting instruction form in support of all of the Company's nominees and resolutions. To ensure your vote is counted, shareholders are encouraged to proactively contact their broker to obtain their 16-digit control number associated with the GREEN management proxy. Once received, you can cast your vote by visiting You may receive materials or outreach from the dissident — please disregard any such communications and vote only using the GREEN proxy in support of the Company's nominees. About MediPharm Labs Founded in 2015, MediPharm Labs specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products utilizing a Good Manufacturing Practices certified facility with ISO standard-built clean rooms. MediPharm Labs has invested in an expert, research driven team, state-of-the-art technology, downstream purification methodologies and purpose-built facilities for delivery of pure, trusted and precision-dosed cannabis products for its customers. MediPharm Labs develops, formulates, processes, packages and distributes cannabis and advanced cannabinoid-based products to domestic and international medical markets. In 2021, MediPharm Labs received a Pharmaceutical Drug Establishment License from Health Canada, becoming the only company in North America to hold a commercial-scale domestic Good Manufacturing Practices License for the extraction of multiple natural cannabinoids. This GMP license was the first step in the Company's current foreign drug manufacturing site registration with the US FDA. In 2023, MediPharm acquired VIVO Cannabis Inc., which expanded MediPharm's reach to medical patients in Canada via Canna Farms medical ecommerce platform, and in Australia and Germany through Beacon Medical Australia PTY Ltd. and Beacon Medical Germany GMBH. This acquisition also included Harvest Medical Clinics in Canada which provides medical cannabis patients with Physician consultations for medical cannabis education and prescriptions. The Company carries out its operations in compliance with all applicable laws in the countries in which it operates. Shareholder Voting Assistance: If you have any questions or require any assistance in executing your GREEN proxy or voting instruction form, please call Sodali & Co at: North American Toll-Free Number: 1.888.777.2059Outside North America, Banks, Brokers and Collect Calls: 1.289.695.3075Email: assistance@ American Toll-Free Facsimile: 1.877.218.5372 For up-to-date information and assistance in voting please visit: Investor Contact: MediPharm Labs Investor RelationsTelephone: +1 416.913.7425Email: investors@ Media Contact: John VincicOakstrom Advisors+1 (647) 402-6375john@ Cautionary Note Regarding Forward-Looking Information: This news release contains 'forward-looking information' and 'forward-looking statements' (collectively, 'forward-looking statements') within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as 'expects', or 'does not expect', 'is expected', 'anticipates' or 'does not anticipate', 'plans', 'budget', 'scheduled', 'forecasts', 'estimates', 'believes' or 'intends' or variations of such words and phrases or stating that certain actions, events or results 'may' or 'could', 'would', 'might' or 'will' be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward-looking statements relate to, among other things: timing of the Annual and Special Meeting, any impacts to MediPharm shareholders of the actions relating to the Applicants or Mr. McGee, and any outcomes resulting from the circumstances and information cited herein. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; the inability of MediPharm Labs to obtain adequate financing; the delay or failure to receive regulatory approvals; and other factors discussed in MediPharm Labs' continuous disclosure filings, available on the SEDAR+ website at There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this news release. Except as required by law, MediPharm Labs assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they in to access your portfolio
Yahoo
17 minutes ago
- Yahoo
Bonterra Resources Announces Election Results of its 2025 Annual General Meeting
Val-d'Or, Quebec--(Newsfile Corp. - June 11, 2025) - Bonterra Resources Inc. (TSXV: BTR) (OTCQX: BONXF) (FSE: 9BR2) ("Bonterra" or the "Company") announces election results of its 2025 annual general meeting held on June 11, 2025 ("2025 AGM"), representing its fiscal year ended 2024. Bonterra is pleased to announce that shareholders have approved all matters voted on at the 2025 AGM, including: (i) to set the number of directors at seven (7); (ii) to re-elect Messrs. Cesar Gonzalez, Marc-André Pelletier, Normand Champigny, Paul Jacobi, Matt Houk, Lesley Antoun and Peter O'Malley as Directors; (iii) to appoint the Crowe MacKay LLP, as auditors of the Company for the ensuing year and to authorize the directors to fix their remuneration; and (iv) to consider and, if deemed advisable, adopt with or without variation, an ordinary resolution to approve the Company's Omnibus Equity Incentive Compensation Plan. Details in respect of such matters were provided in the Company's management information circular dated May 6, 2025. A total of 77,193,201 common shares were voted at the Meeting, representing approximately 46% of the common shares issued and outstanding as of the record date. Results from the vote are presented in the table below: Report on Proxies To view an enhanced version of this graphic, please visit: About Bonterra Resources is a Canadian gold exploration company with a portfolio of advanced exploration assets anchored by a central milling facility in Quebec, Canada. The Company's assets include the Gladiator, Barry, Moroy, and Bachelor gold deposits, which collectively hold 1.24 million ounces in Measured and Indicated categories and 1.78 million ounces in the Inferred category. In November 2023, the Company entered into a earn-in and joint venture agreement with Osisko Mining Inc. for the Urban-Barry properties (the "JV Agreement"), which include the Gladiator and Barry deposits. In October 2024, Gold Fields Ltd completed the acquisition of Osisko Mining for C$2.16 billion. Gold Fields is now the counterparty to the JV Agreement and can continue to earn a 70% interest in the joint venture by incurring C$30 million in work expenditures until November 2026 (including expenditures incurred by Osisko Mining prior to October 2024). This strategic transaction highlights Bonterra's dedication to advancing its exploration assets, marking a significant step towards development. FOR ADDITIONAL INFORMATION Marc-André Pelletier, President & CEOir@ 2872 Sullivan Road, Suite 2, Val d'Or, Quebec J9P 0B9819-825-8678 | Website: Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Caution regarding forward-looking statements This press release contains "forward-looking information" that is based on Bonterra's current expectations, estimates, forecasts, and projections. This forward-looking information includes, among other things, statements with respect to the earn-in and joint venture agreement with Osisko Mining announced on November 28, 2023. The words "will", "anticipated", "plans" or other similar words and phrases are intended to identify forward-looking information. This forward-looking information includes namely information with respect to the planned exploration programs and the potential growth in mineral resources. Exploration results that include drill results on wide spacing may not be indicative of the occurrence of a mineral deposit and such results do not provide assurance that further work will establish sufficient grade, continuity, metallurgical characteristics, and economic potential to be classed as a category of mineral resource. The potential quantities and grades of drilling targets are conceptual in nature and, there has been insufficient exploration to define a mineral resource, and it is uncertain if further exploration will result in the targets being delineated as mineral resources. Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause Bonterra's actual results, level of activity, performance, or achievements to be materially different from those expressed or implied by such forward-looking information. Such factors include but are not limited to: uncertainties related exploration and development; the ability to raise sufficient capital to fund exploration and development; changes in economic conditions or financial markets, environmental and other judicial, regulatory, political, and competitive developments; technological or operational difficulties or inability to obtain permits encountered in connection with exploration activities; and labour relations matters. This list is not exhaustive of the factors that may affect our forward-looking information. These and other factors should be considered carefully, and readers should not place undue reliance on such forward-looking information. To view the source version of this press release, please visit Sign in to access your portfolio
Yahoo
20 minutes ago
- Yahoo
Thunderbird Entertainment Retains Three Part Advisors for Its Investor Relations Program
VANCOUVER, British Columbia, June 11, 2025--(BUSINESS WIRE)--Thunderbird Entertainment Group Inc. (TSXV: TBRD, OTCQX: THBRF) ("Thunderbird" or the "Company") is pleased to announce that it has retained Three Part Advisors, LLC ("Three Part Advisors"), a leading full-service, strategic investor relations advisory firm headquartered near Dallas, Texas, for its ongoing investor relationship program, effective July 1, 2025. Three Part Advisors will work closely with management on the Company's strategic investor relations program, with a focus on enhancing Thunderbird's visibility within the investment community. This includes, but is not limited to, identifying and engaging with potential investors, organizing investor presentations and meetings with interested parties, responding to incoming calls from shareholders and potential investors, and providing general capital markets advisory services. Jennifer Twiner McCarron, CEO and Chair of Thunderbird, commented, "We're pleased to welcome Three Part Advisors as our new strategic investor relations advisory firm. Given our significant growth plans and the health of our business, we believe this is an opportune time to share the Thunderbird story with a broader investor audience." Steven Hooser, Partner of Three Part Advisors, said, "We are thrilled to welcome Thunderbird Entertainment to our growing base of diverse clients. We know that introducing the Company to the right investors looking for growth and a strong management team is vital, and Thunderbird has built a global content creation studio of premium, award-winning content and distribution that will generate excitement from fundamental investors across our network." Three Part Advisors has been retained for an initial period of one year, commencing July 1, 2025, at a rate of $12,500 USD per month. Three Part Advisors has no interest, directly or indirectly, in the Company or its securities, or any right or intent to acquire such an interest, other than as described herein. Market Making Services Correction Thunderbird is correcting language from an announcement made on October 23, 2024. The agreement with the Independent Trading Group to provide market making services in accordance with TSX Venture Exchange policies was for an initial term of one month and renewable thereafter. About Three Part Advisors, LLC Three Part Advisors, LLC is a leading full-service, strategic investor relations advisory firm. Through measurable and proactive investor relations programs, the firm helps clients develop their investment thesis, effectively communicate the strategy to Wall Street, meet new investors and ultimately, lower the cost of capital. Three Part Advisors also provides corporate design services and annually holds three independent IDEAS investor conferences ( Unbiased by investment banking fees and trading commissions, Three Part Advisors has a proven reputation for engaging with companies that are supported by strong investment merits and proven fundamentals, and proactively communicating their stories to Wall Street in the most effective manner. More information is available at About Thunderbird Entertainment Thunderbird Entertainment (TSXV: TBRD, OTCQX: THBRF) is a global award-winning, full-service multiplatform production, distribution and rights management company, headquartered in Vancouver, with teams in Los Angeles and Ottawa. Thunderbird creates award-winning scripted, unscripted, and animated programming for the world's leading digital platforms, as well as Canadian and international broadcasters. The Company develops, produces, and distributes animated, factual, and scripted content through its various content arms, including Thunderbird Kids and Family (Atomic Cartoons), Thunderbird Unscripted (Great Pacific Media) and Thunderbird Scripted. Productions under the Thunderbird umbrella include Mermicorno: Starfall, Super Team Canada, Molly of Denali, Highway Thru Hell, Kim's Convenience, Boot Camp and Sidelined: The QB and Me. Thunderbird Distribution and Thunderbird Brands manage global media and consumer products rights, respectively, for the Company and select third parties. Thunderbird is on Facebook, X, and Instagram at @tbirdent. For more information, visit: Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release, which has been prepared by management. Cautionary Statement Regarding Forward-Looking Information Certain statements contained in this news release may contain forward-looking information or may be forward-looking statements (collectively, "forward-looking statements") within the meaning of applicable securities laws. Forward-looking statements may be identified by words such as "anticipate", "continue", "estimate", "expect", "forecast", "may", "will", "plan", "project", "should", "believe", "intend", or similar expressions concerning matters that are not historical facts. Forward-looking statements in this press release include, but are not limited to, statements regarding Thunderbird's retention of Three Part Advisors, LLC as its new investor relations advisory firm, the anticipated benefits of this engagement, including enhancing Thunderbird's visibility within the investment community, increasing investor awareness and engagement, supporting the Company's growth and shareholder value, and the implementation of a proactive investor awareness program aimed at increasing shareholder engagement, trading volume, and attracting long-term investors. Forward-looking statements are necessarily based on a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties and other factors which may cause actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic and social uncertainties; litigation, legislative, environmental and other judicial, regulatory, political and competitive developments; product capability and acceptance; international risk and currency exchange rates; and technology changes. The forward-looking statements or information contained in this document represent our views as of the date hereof and as such information should not be relied upon as representing our views as of any date subsequent to the date of this document. The Company undertakes no obligation to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws. Accordingly, readers are cautioned not to place undue reliance on forward-looking statements or information. View source version on Contacts Media Relations & Corporate Communications: Julia Smith, Finch MediaEmail: Julia@
